June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol
Author Affiliations & Notes
  • Sebastian Mueller
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Rebecca Dollinger
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Sebastian Thaler
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Johanna Hofmann
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Martin Spitzer
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Karl Bartz-Schmidt
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Peter Szurman
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Kai Januschowski
    Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships Sebastian Mueller, None; Rebecca Dollinger, None; Sebastian Thaler, None; Johanna Hofmann, None; Martin Spitzer, None; Karl Bartz-Schmidt, None; Peter Szurman, None; Kai Januschowski, TheraMon (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 413. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sebastian Mueller, Rebecca Dollinger, Sebastian Thaler, Johanna Hofmann, Martin Spitzer, Karl Bartz-Schmidt, Peter Szurman, Kai Januschowski; Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol. Invest. Ophthalmol. Vis. Sci. 2013;54(15):413.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Tempol is a low weight antioxidant that can act as a superoxide dismutase thus preventing the production of radicals via oxidation of Fe(II). Oxidative stress tributes to apoptotic cell death, a main reason for retinal ganglion cell (RGC) degeneration in glaucoma. Tempol already showed neuroprotective effects in models of brain trauma, ischemic stroke and Parkinson’s disease. This study evaluated the retinal tolerance to different concentrations of tempol in a model of isolated and perfused bovine retina by measuring an electroretinogramm (ERG) and performing an MTT stationary toxicity assay on retinal gangion cell cultures.

Methods: For functionality testing bovine retinas were prepared and perfused with an oxygen saturated standard solution and the ERG was recorded until stable b-wave amplitudes were recorded. 0.5 mM, 1 mM, 2 mM or 5 mM tempol concentrations were tested for 45 minutes. To investigate the effects on photoreceptor function 1 mM asparate was added to obtain a-waves. ERG-recovery was monitored for 110 minutes. For cytotoxicity testing concentrations of 0.1 mM, 1 mM, 2.5 mM, 5mM, 10mM, 25mM, 40mM and 50mM tempol were tested on retinal ganglion cell lines (RGC 5).

Results: While no toxic effects for a concentration of 0.5 mM and 1 mM tempol could be detected, starting from a concentration of 2 mM tempol, statistically significant effects on the b-wave amplitude were noted (48%, p= 0.007 for 2 mM). The a-wave amplitude remained stable even at higher concentrations of 10 mM. RGC 5 displayed a higher tolerance towards tempol with toxic effects starting at 50 mM (cell viability 86.46%, p<0.05).

Conclusions: Although the photoreceptors seem to display a tolerance to higher concentrations of tempol, higher doses than 1mM should be avoided.

Keywords: 615 neuroprotection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×